Grasim Industries Limited has filed its quarterly monitoring agency report for the period ended December 31, 2025, confirming compliance with regulatory requirements and no deviation in fund utilization from its rights issue proceeds. The report was submitted to BSE Limited and National Stock Exchange of India Limited on February 10, 2026.

Rights Issue Overview

The company's rights issue, conducted from January 17, 2024, to January 29, 2024, raised ₹3,999.80 crore through the allotment of 2,20,70,910 equity shares at ₹1,812 per share. CARE Ratings Limited serves as the monitoring agency for tracking the utilization of these proceeds.

Fund Utilization Progress

The monitoring report reveals that during Q3FY26, the company utilized ₹0.65 crore from the rights issue proceeds specifically for general corporate purposes, primarily towards salary payments. The total amount allocated for general corporate purposes in the offer document was ₹977.65 crore.

Monitoring Account Status

As of December 31, 2025, the company maintains ₹0.14 crore in its Axis Bank monitoring account. The report indicates that while unutilized general corporate purpose proceeds stand at ₹0.21 crore, the actual monitoring account balance is lower due to the utilization of issue expense proceeds towards general corporate purposes in Q4FY25.

Regulatory Compliance

The monitoring agency report confirms full compliance with SEBI regulations, specifically Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 82(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was verified by Nerkar & Co., a peer-reviewed audit firm, through their certificate dated February 03, 2026.

Key Confirmations

The monitoring agency report provides several key confirmations regarding the rights issue proceeds:

• All utilization aligns with disclosures in the offer document
• No material deviations from expenditures disclosed in the offer document
• No changes in the means of finance for disclosed objects
• No major deviations observed from earlier monitoring reports
• No unfavorable events affecting the viability of stated objects

The company's promoter shareholding increased from 42.75% as of December 31, 2023, to 43.22% as of December 31, 2025, following the rights issue. The report confirms that there remains a pending amount of ₹5.01 crore to be collected from investors, with the company having until March 2027 to utilize the net proceeds according to the offer document terms.

Grasim Industries Limited has announced the grant of 2,676 stock options to eligible employees under its Employee Stock Option and Performance Stock Unit Scheme 2022. The Nomination and Remuneration Committee of the Board of Directors approved this grant during its meeting held on February 10, 2026.

Stock Option Grant Details

The total grant comprises two distinct categories of stock options allocated to eligible employees:

The scheme operates through the Grasim Employees' Welfare Trust and complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Pricing Structure

The exercise prices for the two categories of stock options differ significantly:

The ESOP exercise price of Rs. 2,926.30 per option is based on the market price as of February 9, 2026, in accordance with applicable SEBI regulations.

Vesting and Exercise Terms

The scheme features distinct vesting schedules for different option types:

ESOP Vesting:

• 33% vesting each year over three years
• First vesting occurs after completion of one year from grant date

PSU Vesting:

• 100% vesting at the end of three years from grant date

Exercise Period:

• Stock options must be exercised within five years from the date of vesting
• All ESOPs and PSUs are subject to performance conditions for vesting

Regulatory Compliance

The grant was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed BSE Limited (Scrip Code: 500300) and National Stock Exchange of India Limited (Symbol: GRASIM) about this development. The scheme aligns with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, ensuring regulatory compliance for the employee benefit program.